The Effect of Renin Inhibition on Nerve Function in Diabetes

Completed · Not applicable · Has a placebo group

Conditions studied: Diabetes

In brief

This study will assess the effect of direct renin inhibition on nerve function in persons with diabetes using a double-blind, placebo-controlled randomized trial involving two treatment arms (i.e., \[1\] 30 participants enrolled and randomized to 300 mg of Aliskiren; \[2\] 30 participants enrolled and randomized to placebo).

Key facts

Study ID
NCT00935064
Run by
Christiana Care Health Services
People needed
60
Starts
2009-06-01
Expected to finish
2012-04-01
Last updated by the study team
2016-08-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.